Wells Fargo’s Cyclerion Therapeutics CYCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15
| Closed | -$48 | – | 6607 |
|
|
2024
Q1 | $48 | Hold |
15
| – | – | ﹤0.01% | 6446 |
|
|
2023
Q4 | $50 | Buy |
15
+1
| +7% | +$3 | ﹤0.01% | 6486 |
|
|
2023
Q3 | $48 | Hold |
14
| – | – | ﹤0.01% | 6549 |
|
|
2023
Q2 | $58 | Sell |
14
-257
| -95% | -$1.07K | ﹤0.01% | 6709 |
|
|
2023
Q1 | $118 | Sell |
271
-2,096
| -89% | -$913 | ﹤0.01% | 6579 |
|
|
2022
Q4 | $1.55K | Buy |
2,367
+2,007
| +558% | +$1.32K | ﹤0.01% | 5740 |
|
|
2022
Q3 | $0 | Sell |
360
-40
| -10% | – | ﹤0.01% | 6421 |
|
|
2022
Q2 | $0 | Buy |
400
+24
| +6% | – | ﹤0.01% | 6586 |
|
|
2022
Q1 | $0 | Buy |
376
+2
| +0.5% | – | ﹤0.01% | 6732 |
|
|
2021
Q4 | $0 | Sell |
374
-6
| -2% | – | ﹤0.01% | 6720 |
|
|
2021
Q3 | $1K | Buy |
380
+65
| +21% | +$171 | ﹤0.01% | 6345 |
|
|
2021
Q2 | $1K | Sell |
315
-7,493
| -96% | -$23.8K | ﹤0.01% | 6297 |
|
|
2021
Q1 | $21K | Sell |
7,808
-42,714
| -85% | -$115K | ﹤0.01% | 5767 |
|
|
2020
Q4 | $154K | Buy |
50,522
+22,130
| +78% | +$67.5K | ﹤0.01% | 5045 |
|
|
2020
Q3 | $173K | Sell |
28,392
-6,281
| -18% | -$38.3K | ﹤0.01% | 4850 |
|
|
2020
Q2 | $205K | Sell |
34,673
-20,230
| -37% | -$120K | ﹤0.01% | 4730 |
|
|
2020
Q1 | $145K | Buy |
54,903
+11,383
| +26% | +$30.1K | ﹤0.01% | 4689 |
|
|
2019
Q4 | $118K | Sell |
43,520
-15,976
| -27% | -$43.3K | ﹤0.01% | 5022 |
|
|
2019
Q3 | $722K | Buy |
59,496
+23,944
| +67% | +$291K | ﹤0.01% | 4016 |
|
|
2019
Q2 | $408K | Buy |
+35,552
| New | +$408K | ﹤0.01% | 4394 |
|